Changes

Human embryos in medical research

31 bytes added, 18:57, November 28, 2007
/* Expectation and Potential */
Jeremy Pearce of the ''New York Times'' wrote:
*Dr. [[Ira B. Black]], chairman of the neurosciences and cell biology department of the Robert Wood Johnson Medical School, at the University of Medicine and Dentistry of New Jersey, described the potential of all stem-cell research as threefold. He said the expectation in the laboratory was for such cells to revive damaged and dead cells; to act as vehicle cells in introducing [[gene therapy]]; and, finally, to rally and harness the [[human body]]'s own existing stem cells.
*The end goal would be to replace [[brain cells ]] lost to [[Alzheimer's]], repair injured nerve cells causing [[paralysis ]] and treat [[cancers]], malfunctioning [[organs ]] and other now-irreparable conditions.
*To Dr. Black, the use of embryonic cells ''fundamentally constitutes the gold standard'' in medical research because of their purity and versatility. But he cautioned: ''This is a very young field. Our areas of ignorance are far greater than our areas of knowledge.'' [http://query.nytimes.com/gst/fullpage.html?res=9500E3DD1739F93BA25752C0A9629C8B63&sec=&spon=&pagewanted=print]
 
== References ==
Siteadmin, check user, nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW, oversight, Administrator
30,428
edits